Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-19,215
Closed -$1M – 5943
2026
Q2
$1M Buy
+19,215
New +$1M ﹤0.01% 2177
2023
Q1
– Sell
-2,227
Closed -$27K – 3248
2022
Q4
$27K Sell
2,227
-6,949
-76% -$74.7K ﹤0.01% 2154
2022
Q3
$73K Buy
9,176
+6,164
+205% +$67.5K ﹤0.01% 2417
2022
Q2
$34K Buy
3,012
+86
+3% +$1.15K ﹤0.01% 2551
2022
Q1
$49K Buy
+2,926
New +$79.5K ﹤0.01% 2750
2021
Q4
– Sell
-1,515
Closed -$78K – 4143
2021
Q3
$78K Buy
+1,515
New +$72.8K ﹤0.01% 2966
2021
Q2
– Sell
-1,510
Closed -$66K – 3578
2021
Q1
$66K Buy
1,510
+363
+32% +$15.9K ﹤0.01% 2509
2020
Q4
$43K Sell
1,147
-58,302
-98% -$2.08M ﹤0.01% 1703
2020
Q3
$1.87M Buy
+59,449
New +$2.29M 0.05% 269
2019
Q2
– Sell
-2,790
Closed -$145K – 925
2019
Q1
$145K Buy
+2,790
New +$174K 0.02% 420

Other funds holding VEON

HRT Financial's VEON Position: Q3 2026 in Review

HRT Financial sold out of VEON (VEON) in Q3 2026, closing a stake of 19,215 shares — an estimated $1M sold.

HRT Financial first reported a position in VEON in Q1 2019 and held it in 10 quarters. The position peaked at $1.87M in Q3 2020. 124 funds tracked by Wall St. Rank hold VEON as of Q3 2026.

  • HRT Financial reported no remaining VEON position as of Q3 2026 after selling out during the quarter.
  • HRT Financial sold 19,215 VEON shares in Q3 2026, an estimated $1M.
  • HRT Financial first reported a position in VEON in Q1 2019 and held it in 10 quarters.
  • HRT Financial's VEON position peaked at $1.87M in Q3 2020.
  • 124 funds tracked by Wall St. Rank held VEON as of Q3 2026.

Based on HRT Financial's 13F filing for Q3 2026, filed 13 Nov 2026.